Corifollitropin alfa N02 Injection(Xinlitai)

绒促卵泡激素α N02

Report date: 2025/10/27 18:00:39

Base Information

Drug NameCorifollitropin alfa N02 Injection(Xinlitai)
Drug Alias Name重组人促卵泡激素-CTP融合蛋白绒促卵泡激素α N02注射液重组人促卵泡激素-CTP 融合蛋白注射液（长效FSH-CTP）金赛佳SAL-016 +[7] 
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionFollicle-stimulating hormone receptor agonists
TargetsFollicle-stimulating hormone receptor
Therapy Area/IndicationsIdiopathie hypogonadotropic hypogonadismHypogonadismInfertility, Female +[6] 
Global Approved IndicationsInfertility, Female
Approved Indications in ChinaInfertility, Female
Original Approved Country/TerritoryMainland China
Original Approved Date2025/09/23
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesChangchun GeneScience Pharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSuzhou Genemen Biotech Co LtdChangchun GeneScience Pharmaceuticals Co LtdXinlitai (Chengdu) Biological Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsIdiopathie hypogonadotropic hypogonadismHypogonadismInfertility, Female +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A